Toni Choueiri, MD
drchoueiri.bsky.social
Toni Choueiri, MD
@drchoueiri.bsky.social
Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Kohberg Professor of Medicine, Harvard Medical School
Reposted by Toni Choueiri, MD
In 2023, the @fda.gov approved belzutifan for certain kidney cancers –– thanks to years of work led by Nobel Prize recipient William G. Kaelin Jr., MD. Now, @drchoueiri.bsky.social, director of our Lank Center for Genitourinary Oncology, and team are working to expand its clinical use.
Chain Reaction: The Belzutifan Journey | Dana-Farber Cancer Institute
Basic science discoveries made by Dana-Farber's William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer.
bit.ly
June 5, 2025 at 10:00 PM
Reposted by Toni Choueiri, MD
@drchoueiri.bsky.social‬ discusses promising results from the phase 1 ARC-20 study, exploring the combination of Casdatifan and cabozantinib in patients with previously treated clear cell renal cell carcinoma. #ASCO25
June 1, 2025 at 4:55 PM
1 week left to support @danafarber.bsky.social & Gronk Nation Youth Foundation! Help us finish strong + take on @RobGronkowski!

🎟️ $187+ = ticket to the event
🏈 $100+ = chance to win signed Gronk football
👀 Gronk, Edelman, Ninkovich, Chung
📅 Deadline: May 20

🔗 charity.pledgeit.org/pickleball/t...
Support Kancer Killers - Pickleball for a Purpose 2025
We're excited to join this incredible initiative! This organization's mission is very important to us and we're proud to help them make a difference. Please support us by giving to our page. Every dol...
charity.pledgeit.org
May 14, 2025 at 5:05 AM
“I can imagine no heroism greater than motherhood." - Happy Mothers day mom and all the mothers in the world ! #HappyMothersDay2025
May 11, 2025 at 1:08 PM
Reposted by Toni Choueiri, MD
We’re getting ready to wrap up #AACR25 today, but not before once again congratulating @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social and Alice T. Shaw, MD, PhD, for receiving @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om
April 30, 2025 at 3:00 PM
Thank you @theaacr.bsky.social for the Waun Ki Hong Award!

My talk will be addressing Precision Medicine in Renal Cell Carcinoma. See you in Chicago!

cc: @danafarber.bsky.social
April 25, 2025 at 8:27 PM
Our own @danafarber.bsky.social Dr. @NarjustFlorezMD is running for @iaslc.bsky.social Board. Let us support NJ! @narjustflorezmd.bsky.social

@danafarbernews.bsky.social
April 19, 2025 at 7:14 PM
Thank you @theaacr.bsky.social for this honor !
Congratulations to @danafarbernews.bsky.social’s Matthew Meyerson, MD, PhD, FAACR, @drchoueiri.bsky.social, and Alice T. Shaw, MD, PhD, recipients of @theaacr.bsky.social 2025 Scientific Achievement Awards. bit.ly/4j7m8om
April 14, 2025 at 4:36 PM
Reposted by Toni Choueiri, MD
“Our focused efforts are yielding results that are helping patients today and guiding our research towards more advances in the future,” says @drchoueiri.bsky.social. Learn about the research advancements our Lank Center for Genitourinary Oncology has made this past year.
A Year of Advances in Genitourinary Cancer
Published: February 6, 2025Written by: Beth DoughertyMedically Reviewed By: Atish Choudhury, MD, PhD, Toni Choueiri, MD, and Mark Pomerantz, MDDana-Farber’s genitourinary cancer team is devoted to res...
bit.ly
April 11, 2025 at 3:01 PM
Reposted by Toni Choueiri, MD
💬 Transatlantic Exchange : interview croisée du Dr @drchoueiri.bsky.social & du Pr Karim Fizazi.

Le 19 mars s’est tenue à Paris la 4e édition des Transatlantic Exchanges, une journée scientifique co-organisée par @gustaveroussy.fr et le @danafarber.bsky.social.

April 11, 2025 at 11:22 AM
“It may be that the satisfaction I need depends on my going away, so that when I've gone and come back, I'll find it at home”—Rumi, 13th century
April 5, 2025 at 11:07 AM
Another year, another #pickeball tournament with our good friend Rob Gronkowski #DaGronk to benefit our Research and Gronk Nation Youth Foundation. Join me and
donate at:

charity.pledgeit.org/pickleball/@to… #curecancere#beatgronknk
April 2, 2025 at 8:58 PM
This weekend, thanks to the support of the @redsox.com, @danafarber.bsky.social & @thejimmyfund.bsky.social gathered @fenwaypark.bsky.social to celebrate the impact of our Campaign. We celebrated our donors who help us defy Cancer together !
April 1, 2025 at 1:30 AM
Reposted by Toni Choueiri, MD
Yesterday, @drchoueiri.bsky.social and Karim Fizazi, MD, PhD, kicked off The Fourth Transatlantic Exchange in Oncology: Radiopharmaceutical Therapy Meets Oncology. Learn more about the collaborative event with @gustaveroussy.fr: bit.ly/42fC69Z
March 20, 2025 at 1:02 PM
Thank you @TownofWestwood and Lenny Strauss for highlighting our @PanMass journey the past several years, both @mvmombo and I. We are committed @DanaFarber to end Cancer!

hometownweekly.net/westwood/dr-ch…

Our @CowbellTeam Link for donations to cure Cancer: teammorecowbell.com/
https://hometownweekly.net/westwood/dr-ch…
March 14, 2025 at 2:36 PM
Happy International Women’s day to the wonderful GU Oncology Women’s @danafarber.bsky.social (front row)
March 8, 2025 at 9:59 PM
Our new paper in JITC with a group of fine international friends, mentees and colleagues about immunotherapy in patients with cardiac metastasis.

jitc.bmj.com/content/13/3/e…

@danafarber.bsky.soci
al jitc.bmj.com/content/13/3...64
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study
Background Data on the safety profiles and clinical outcomes of patients with solid tumors and cardiac metastasis treated with immune checkpoint inhibitors (ICIs) are limited. Methods This is an inte...
jitc.bmj.com
March 7, 2025 at 2:03 AM
Reposted by Toni Choueiri, MD
Promising results: Adjuvant neoantigen vaccination prevents recurrence of kidney cancer bit.ly/3EUpSKG  @danafarber.bsky.social  @braunmdphd.bsky.social  @yalecancer.bsky.social  @drchoueiri.bsky.social
February 19, 2025 at 7:01 PM
#GU25 was an outstanding @ascocancer.bsky.social meeting: catching up with friends/ colleagues, watching mentees grow, learn up-to-date GU cancers management, and presenting a new HIF-2 inhibitor (casdatifan) data. Energized! The future is bright!

@danafarber.bsky.social @jrgralow.bsky.social
February 16, 2025 at 9:54 PM
Great @ascocancer.bsky.social #GU25 catching up with many friends ! @jrgralow.bsky.social
February 15, 2025 at 11:20 PM
Reposted by Toni Choueiri, MD
Updated results from the phase 2 LITESPARK-003 study on belzutifan + cabozantinib in advanced ccRCC patients! 📊💡 Key insights into combination therapy and improved outcomes @ascocancer.bsky.social #GU25 @drchoueiri.bsky.social
February 15, 2025 at 6:33 PM
Reposted by Toni Choueiri, MD
Great to have @drchoueiri.bsky.social stop by our poster @ascocancer.bsky.social #GU25! Appreciate the insightful discussion and your time.
February 15, 2025 at 6:43 PM
Reposted by Toni Choueiri, MD
A customized kidney cancer vaccine made from patients’ tumors looked promising in a small study, @drchoueiri.bsky.social et al report in @nature.com. None of the 9 treated people experienced recurrence. Larger trial of mRNA vaccine underway.
www.cancerhealth.com/article/pers...
Personalized Vaccine May Help Prevent Kidney Cancer Recurrence
None of the nine patients who received the vaccine after surgery experienced recurrence over three years.
www.cancerhealth.com
February 15, 2025 at 10:35 PM